Pages that link to "Q44212864"

The following pages link to Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide (Q44212864):

Displaying 27 items.

• Interactions of AChE with A? Aggregates in Alzheimer?s Brain: Therapeutic Relevance of IDN 5706 (Q21129335) (← links)
• ALS mutants of human superoxide dismutase form fibrous aggregates via framework destabilization (Q27641993) (← links)
• Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential (Q29994589) (← links)
• Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease (Q33291757) (← links)
• Structural elements regulating amyloidogenesis: a cholinesterase model system (Q33324410) (← links)
• Model discrimination and mechanistic interpretation of kinetic data in protein aggregation studies (Q33427240) (← links)
• Conformational preferences of a 14-residue fibrillogenic peptide from acetylcholinesterase (Q33813457) (← links)
• A mechanistic model for amorphous protein aggregation of immunoglobulin-like domains. (Q34334001) (← links)
• Alzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection? (Q35165703) (← links)
• A metabolomic and systems biology perspective on the brain of the fragile X syndrome mouse model (Q35581584) (← links)
• AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease (Q36925910) (← links)
• Acetylcholinesterase and apoptosis. A novel perspective for an old enzyme (Q37060537) (← links)
• Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides. (Q37060542) (← links)
• Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus (Q38262767) (← links)
• Perspectives on Inhibiting β-Amyloid Aggregation through Structure-Based Drug Design (Q38558352) (← links)
• Tumor cell migration is inhibited by a novel therapeutic strategy antagonizing the alpha-7 receptor (Q39026082) (← links)
• Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders. (Q39097245) (← links)
• Detecting hidden sequence propensity for amyloid fibril formation (Q41882613) (← links)
• The Role of Hydrophobic Interactions in Amyloidogenesis: Example of Prion-Related Polypeptides (Q44654710) (← links)
• The C-terminal t peptide of acetylcholinesterase forms an alpha helix that supports homomeric and heteromeric interactions (Q44700289) (← links)
• Respective roles of the catalytic domains and C-terminal tail peptides in the oligomerization and secretory trafficking of human acetylcholinesterase and butyrylcholinesterase (Q46238513) (← links)
• Monitoring of neuronal loss in the hippocampus of Aβ-injected rat: autophagy, mitophagy, and mitochondrial biogenesis stand against apoptosis. (Q46974292) (← links)
• Rapid method for measurement of surface tension in multiwell plates (Q47214929) (← links)
• A new motif in the N-terminal of acetylcholinesterase triggers amyloid-β aggregation and deposition (Q47688215) (← links)
• Modulatory Effects of a Novel Cyclized Peptide in Reducing the Expression of Markers Linked to Alzheimer's Disease. (Q55367685) (← links)
• A Multidisciplinary Approach Reveals an Age-Dependent Expression of a Novel Bioactive Peptide, Already Involved in Neurodegeneration, in the Postnatal Rat Forebrain. (Q64990418) (← links)
• Effect of introducing a short amyloidogenic sequence from the Aβ peptide at the N‐terminus of 18‐residue amphipathic helical peptides (Q82341308) (← links)